Sathiyamoorthi Sathiyanarayanan, Tiwari Utkarsha, Muralikrishnan Sreelakshmi, Aravindakshan Rajeev, Ganapathy Kalaiselvan
Community and Family Medicine, All India Institute of Medical Sciences, Mangalagiri, Mangalagiri, IND.
Cureus. 2025 Apr 9;17(4):e81939. doi: 10.7759/cureus.81939. eCollection 2025 Apr.
Background Tuberculosis (TB) control in India faces significant challenges, exacerbated by the COVID-19 pandemic, which disrupted healthcare services. This study assesses the pandemic's impact on TB case trends, patient characteristics, and program effectiveness in a primary TB treatment unit in Andhra Pradesh. Objectives The aim was to study and analyze the trends and morbidity profiles of tuberculosis patients in the target population during the pandemic years. Methodology A retrospective analysis was conducted on 727 TB patients registered at an urban tuberculosis unit from 2018-2023. Data from a digital portal and patient records were statistically analyzed for socio-demographic details, diagnostic information, treatment outcomes, and follow-up assessments. Tests of significance were used for parametric and nonparametric data. The chi-square test and Fisher's exact test were used to assess qualitative variables. Trend analysis was done by an interrupted time series analysis and graphically. A p-value< 0.05 was considered a significant association. Results A decline of 41.8% (pre-COVID-19: 318 cases, COVID-19: 185 cases) occurred in TB case detection during the COVID-19 period compared to pre-COVID-19 levels, with only partial recovery post-COVID-19. The prevalence of diabetes mellitus (54, 24.2%) and HIV reactivity (11, 4.91%) among TB patients increased post-COVID-19. Follow-up assessments were significantly disrupted, with only 195 (26.8%) patients followed up after both intensive and continuous phases of treatment overall. Conclusion The COVID-19 pandemic had a substantial negative impact on TB case notification, patient follow-up, and potential treatment outcomes. Strengthening the implementation of the TB program, improving follow-up monitoring, and addressing challenges faced by healthcare staff and patients are crucial to mitigating the long-term effects and improving future pandemic preparedness.
背景 印度的结核病控制面临重大挑战,而新冠疫情使这些挑战更加严峻,因为疫情扰乱了医疗服务。本研究评估了疫情对安得拉邦一个初级结核病治疗单位的结核病病例趋势、患者特征及项目有效性的影响。
目的 旨在研究和分析疫情期间目标人群中结核病患者的趋势和发病情况。
方法 对2018年至2023年在一个城市结核病单位登记的727例结核病患者进行回顾性分析。对来自数字平台和患者记录的数据进行统计分析,以获取社会人口学细节、诊断信息、治疗结果及随访评估。对参数和非参数数据进行显著性检验。使用卡方检验和费舍尔精确检验评估定性变量。通过中断时间序列分析和图表进行趋势分析。p值<0.05被视为具有显著相关性。
结果 与新冠疫情前相比,新冠疫情期间结核病病例检测下降了41.8%(新冠疫情前:318例,新冠疫情期间:185例),新冠疫情后仅部分恢复。新冠疫情后结核病患者中糖尿病患病率(54例,24.2%)和HIV反应性(11例,4.91%)有所增加。随访评估受到严重干扰,总体上在强化期和持续期治疗后仅有195例(26.8%)患者接受了随访。
结论 新冠疫情对结核病病例通报、患者随访及潜在治疗结果产生了重大负面影响。加强结核病项目的实施、改善随访监测以及应对医护人员和患者面临的挑战对于减轻长期影响和提高未来疫情防范能力至关重要。